Healthcare Nanotechnology (Nanomedicine) Market 2028 By Application, Disease and Geography | The Insight Partners

report image

Healthcare Nanotechnology (Nanomedicine) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Drug Delivery, Biomaterials, Active Implants, Diagnostic Imaging, Tissue Regeneration, Other Applications); Disease (Cardiovascular Diseases, Oncological Diseases, Neurological Diseases, Orthopedic Diseases, Infectious Diseases, Other Diseases) and Geography

Report Code: TIPRE00007260 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


Nanotechnology is one of the most rapidly evolving technologies nowadays. Nanotechnology refers to technological developments on a scale of 0.1 to 100 nanometers. Nanomedicine is a branch of nanotechnology that focuses on developing medicines at the molecular level for illness prevention, diagnosis, therapy, and potentially tissue and organ regeneration. As a result, it contributes to the preservation and advancement of human health. Parkinson's disease, Alzheimer's disease, cancer, diabetes, blood-related diseases, lungs, orthopaedic issues, neurological, and cardiovascular problems are all can be treated with the help of nanomedicine.


The "Global Healthcare Nanotechnology (Nanomedicine) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the healthcare nanotechnology (nanomedicine) market with detailed market segmentation by application and disease. The report provides key statistics on the market status of the leading healthcare nanotechnology (nanomedicine) market players and offers key trends and opportunities in the market.


  •   Based on application the market is segmented as, drug delivery, biomaterials, active implants, diagnostic imaging, tissue regeneration, and other applications.
  •   Based on disease the market is segmented as, cardiovascular diseases, oncological diseases, neurological diseases, orthopedic diseases, infectious diseases, and other diseases.


  •   Increasing prevalence of life threatening chronic disorders is the key driving factor for the market growth.
  •   Increasing R&D activities to develop and launch novel drug delivery approches is also expected to spur the market growth.
  •   Gowing fundings for research and development activities.
  •   Technological advancements in biopharmaceutical and pharmaceutical industry.


  •   Whereas, presence of stringent regulatory framework along with long approval process are likley to hamper market growth during the forecast period.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The healthcare nanotechnology (nanomedicine) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the healthcare nanotechnology (nanomedicine) market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Get more information on this report :


The report covers key developments in the healthcare nanotechnology (nanomedicine) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from healthcare nanotechnology (nanomedicine) market are anticipated to lucrative growth opportunities in the future with the rising demand for healthcare nanotechnology (nanomedicine) in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the healthcare nanotechnology (nanomedicine) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Pfizer, Inc.
  •   Ablynx N.V
  •   Arrowhead Pharmaceuticals, Inc.
  •   Johnson and Johnson Services, Inc
  •   Luminex Corporation
  •   Leadiant Biosciences, Inc
  •   Nanospectra Biosciences, Inc.
  •   Bristol-Myers Squibb Company
  •   Taiwan Liposome Company, Ltd
  •   Nanobiotix
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Pfizer, Inc.
2. Ablynx N.V
3. Arrowhead Pharmaceuticals, Inc.
4. Johnson and Johnson Services, Inc
5. Luminex Corporation
6. Leadiant Biosciences, Inc
7. Nanospectra Biosciences, Inc.
8. Bristol-Myers Squibb Company
9. Taiwan Liposome Company, Ltd
10. Nanobiotix
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount